Regeneron Pharmaceuticals (REGN) Operating Income Growth (1y) (2010 - 2026)
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Operating Income Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.74 Bn | 130.89 Bn | 2.84 Bn | 8.32% |
| 2 | Regeneron Pharmaceuticals | 85.52 Bn | 77.52 Bn | 3.93 Bn | 19.82% |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 145.20% |
| 4 | Moderna | 58.04 Bn | 52.91 Bn | 52.00 Mn | 10.14% |
| 5 | Revolution Medicines | 44.06 Bn | 44.06 Bn | - | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.88 Bn | 1.53 Bn | 269.85% |
| 7 | Alnylam Pharmaceuticals | 35.46 Bn | 32.15 Bn | 992.69 Mn | 1,528.74% |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | -36.55% |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 99.51% |
| 10 | Incyte | 25.61 Bn | 21.07 Bn | 1.57 Bn | 31.60% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.82% |
| Mar 31, 2026 | 8.65% |
| Dec 31, 2025 | -11.14% |
| Sep 30, 2025 | -12.95% |
| Jun 30, 2025 | 0.93% |
| Mar 31, 2025 | -21.25% |
| Dec 31, 2024 | 1.78% |
| Sep 30, 2024 | 6.17% |
| Jun 30, 2024 | 5.22% |
| Mar 31, 2024 | -20.63% |
| Dec 31, 2023 | -15.16% |
| Sep 30, 2023 | -9.21% |
| Jun 30, 2023 | -8.42% |
| Mar 31, 2023 | -24.78% |
| Dec 31, 2022 | -56.56% |
| Sep 30, 2022 | -33.75% |
| Jun 30, 2022 | -66.84% |
| Mar 31, 2022 | 13.10% |
| Dec 31, 2021 | 126.20% |
| Sep 30, 2021 | 75.41% |